Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Urgcp | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of URGCP mRNA | CTD | PMID:22206623 | Urgcp | Mouse | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31388691 | Urgcp | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Urgcp (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of URGCP mRNA | CTD | PMID:33387578 | Urgcp | Mouse | 2-methylcholine | affects expression | ISO | URGCP (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of URGCP mRNA | CTD | PMID:21179406 | Urgcp | Mouse | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of URGCP mRNA | CTD | PMID:20188158 | Urgcp | Mouse | 4,4'-sulfonyldiphenol | affects methylation | EXP | | 6480464 | bisphenol S affects the methylation of URGCP exon | CTD | PMID:33297965 | Urgcp | Mouse | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Urgcp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of URGCP mRNA | CTD | PMID:36041667 | Urgcp | Mouse | aflatoxin B1 | increases methylation | ISO | URGCP (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of URGCP gene | CTD | PMID:27153756 | Urgcp | Mouse | aristolochic acid A | increases expression | ISO | URGCP (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of URGCP mRNA | CTD | PMID:33212167 | Urgcp | Mouse | benzo[a]pyrene | affects methylation | ISO | URGCP (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of URGCP 5' UTR | CTD | PMID:27901495 | Urgcp | Mouse | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of URGCP intron and Benzo(a)pyrene results in decreased methylation of URGCP promoter | CTD | PMID:27901495 | Urgcp | Mouse | bisphenol A | increases expression | ISO | Urgcp (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of URGCP mRNA | CTD | PMID:25181051 | Urgcp | Mouse | bisphenol A | increases expression | ISO | URGCP (Homo sapiens) | 6480464 | bisphenol A results in increased expression of URGCP mRNA | CTD | PMID:36232920 | Urgcp | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of URGCP mRNA | CTD | PMID:33221593 | Urgcp | Mouse | bisphenol A | multiple interactions | ISO | Urgcp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of URGCP mRNA and [bisphenol A co-treated with Genistein] results in increased methylation of URGCP gene | CTD | PMID:28505145 and PMID:36041667 | Urgcp | Mouse | bisphenol A | increases methylation | ISO | Urgcp (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of URGCP gene | CTD | PMID:28505145 | Urgcp | Mouse | bisphenol F | multiple interactions | ISO | Urgcp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of URGCP mRNA | CTD | PMID:36041667 | Urgcp | Mouse | Dibutyl phosphate | affects expression | ISO | URGCP (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of URGCP mRNA | CTD | PMID:37042841 | Urgcp | Mouse | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of URGCP mRNA | CTD | PMID:24205000 | Urgcp | Mouse | dioxygen | multiple interactions | ISO | Urgcp (Rattus norvegicus) | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of URGCP mRNA | CTD | PMID:33729688 | Urgcp | Mouse | dorsomorphin | multiple interactions | ISO | URGCP (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of URGCP mRNA | CTD | PMID:27188386 | Urgcp | Mouse | doxorubicin | decreases expression | ISO | URGCP (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of URGCP mRNA | CTD | PMID:29803840 | Urgcp | Mouse | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of URGCP mRNA | CTD | PMID:30319688 | Urgcp | Mouse | flutamide | decreases expression | ISO | Urgcp (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of URGCP mRNA | CTD | PMID:24793618 | Urgcp | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of URGCP mRNA | CTD | PMID:22206623 | Urgcp | Mouse | FR900359 | decreases phosphorylation | ISO | URGCP (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of URGCP protein | CTD | PMID:37730182 | Urgcp | Mouse | genistein | multiple interactions | ISO | Urgcp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Genistein] results in increased methylation of URGCP gene | CTD | PMID:28505145 | Urgcp | Mouse | iron dichloride | decreases expression | ISO | URGCP (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of URGCP mRNA | CTD | PMID:35984750 | Urgcp | Mouse | lead(0) | affects expression | ISO | URGCP (Homo sapiens) | 6480464 | Lead affects the expression of URGCP mRNA | CTD | PMID:28903495 | Urgcp | Mouse | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of URGCP mRNA | CTD | PMID:36914120 | Urgcp | Mouse | paracetamol | decreases expression | ISO | URGCP (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of URGCP mRNA | CTD | PMID:21420995 | Urgcp | Mouse | paracetamol | increases expression | ISO | URGCP (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of URGCP mRNA | CTD | PMID:22230336 | Urgcp | Mouse | pentachlorophenol | increases expression | EXP | | 6480464 | Pentachlorophenol results in increased expression of URGCP mRNA | CTD | PMID:23892564 | Urgcp | Mouse | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of URGCP mRNA | CTD | PMID:37995155 | Urgcp | Mouse | SB 431542 | multiple interactions | ISO | URGCP (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of URGCP mRNA | CTD | PMID:27188386 | Urgcp | Mouse | silver atom | decreases expression | EXP | | 6480464 | Silver results in decreased expression of URGCP mRNA | CTD | PMID:27131904 | Urgcp | Mouse | silver(0) | decreases expression | EXP | | 6480464 | Silver results in decreased expression of URGCP mRNA | CTD | PMID:27131904 | Urgcp | Mouse | sodium arsenate | decreases expression | EXP | | 6480464 | sodium arsenate results in decreased expression of URGCP mRNA | CTD | PMID:30953684 | Urgcp | Mouse | triphenyl phosphate | affects expression | ISO | URGCP (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of URGCP mRNA | CTD | PMID:37042841 | Urgcp | Mouse | valproic acid | decreases expression | ISO | URGCP (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of URGCP mRNA | CTD | PMID:29154799 | Urgcp | Mouse | valproic acid | affects expression | ISO | URGCP (Homo sapiens) | 6480464 | Valproic Acid affects the expression of URGCP mRNA | CTD | PMID:25979313 | Urgcp | Mouse | vinclozolin | decreases expression | ISO | Urgcp (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of URGCP mRNA | CTD | PMID:23034163 | Urgcp | Mouse | vorinostat | decreases expression | ISO | URGCP (Homo sapiens) | 6480464 | vorinostat results in decreased expression of URGCP mRNA | CTD | PMID:26272509 | Urgcp | Mouse | vorinostat | multiple interactions | ISO | URGCP (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of URGCP mRNA | CTD | PMID:27188386 | |